Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Gufic BioSciences LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:509079NSE Symbol: GUFICBIOP/E(TTM):62.21
ISIN Demat:INE742B01025Div & Yield %:0.03EPS(TTM):5.42
Book Value(Rs):62.6776943Market Cap ( Cr.):3381.53Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 819.81806.67690.62779.16487.70378.84
Excise Duty0.000.000.000.000.000.00
Net Sales819.81806.67690.62779.16487.70378.84
Other Income 3.622.182.573.103.735.79
Stock Adjustments 24.91-0.5733.3919.39-14.2910.91
Total Income848.34808.28726.58801.65477.14395.54
EXPENDITURE :      
Raw Materials 399.62389.32365.21431.35236.00190.45
Power & Fuel Cost18.4617.6115.2411.009.948.23
Employee Cost 127.19109.6786.7385.6166.2258.59
Other Manufacturing Expenses 29.2528.4324.6727.4218.2015.93
Selling and Administration Expenses 122.19105.2887.6377.9745.9354.08
Miscellaneous Expenses 11.628.489.8817.1613.2010.35
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure708.33658.79589.36650.51389.49337.63
Operating Profit140.01149.48137.22151.1487.6557.90
Interest 24.5216.798.225.3713.6313.91
Gross Profit115.49132.69129.00145.7774.0243.99
Depreciation21.0617.0222.2818.9316.3113.86
Profit Before Tax94.43115.67106.72126.8457.7130.13
Tax18.7426.3728.2132.1517.208.31
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax5.753.17-1.19-1.15-3.72-0.87
Reported Net Profit69.9386.1479.7095.8444.2322.69
Extraordinary Items 0.09-1.670.020.050.020.01
Adjusted Net Profit69.8487.8179.6895.7944.2122.68
Adjst. below Net Profit 0.000.000.000.000.260.00
P & L Balance brought forward352.46267.29188.5593.6849.5827.36
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 1.000.970.970.970.390.47
P & L Balance carried down421.39352.46267.29188.5593.6849.58
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %10.0010.0010.0010.0010.005.00
Earnings Per Share-Unit Curr6.978.598.229.894.562.34
Earnings Per Share(Adj)-Unit Curr6.978.598.229.894.562.34
Book Value-Unit Curr59.9653.1135.8827.7617.8913.34